NewEdge Advisors LLC Cuts Stake in Globe Life Inc. $GL

NewEdge Advisors LLC reduced its position in Globe Life Inc. (NYSE:GL) by 93.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,494 shares of the company’s stock after selling 37,477 shares during the quarter. NewEdge Advisors LLC’s holdings in Globe Life were worth $347,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in GL. Compound Planning Inc. increased its position in Globe Life by 4.3% during the 4th quarter. Compound Planning Inc. now owns 1,968 shares of the company’s stock valued at $275,000 after purchasing an additional 82 shares during the period. Root Financial Partners LLC raised its holdings in shares of Globe Life by 23.3% in the 1st quarter. Root Financial Partners LLC now owns 439 shares of the company’s stock valued at $61,000 after purchasing an additional 83 shares in the last quarter. Parallel Advisors LLC lifted its position in shares of Globe Life by 5.6% in the 4th quarter. Parallel Advisors LLC now owns 1,651 shares of the company’s stock worth $231,000 after purchasing an additional 87 shares during the period. First United Bank & Trust lifted its position in shares of Globe Life by 2.1% in the 1st quarter. First United Bank & Trust now owns 4,355 shares of the company’s stock worth $606,000 after purchasing an additional 90 shares during the period. Finally, EverSource Wealth Advisors LLC lifted its position in shares of Globe Life by 4.0% in the 1st quarter. EverSource Wealth Advisors LLC now owns 2,366 shares of the company’s stock worth $329,000 after purchasing an additional 91 shares during the period. 81.61% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts recently issued reports on GL shares. Keefe, Bruyette & Woods cut their price objective on shares of Globe Life from $192.00 to $190.00 and set an “outperform” rating on the stock in a report on Friday, July 24th. Piper Sandler upped their target price on Globe Life from $175.00 to $200.00 and gave the stock an “overweight” rating in a report on Wednesday, July 15th. Weiss Ratings cut Globe Life from a “buy (b)” rating to a “buy (b-)” rating in a research report on Monday, July 20th. TD Cowen increased their target price on Globe Life from $215.00 to $225.00 and gave the company a “buy” rating in a research report on Wednesday, July 22nd. Finally, Morgan Stanley lifted their price target on Globe Life from $181.00 to $208.00 and gave the company an “overweight” rating in a report on Monday, July 6th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, Globe Life currently has a consensus rating of “Moderate Buy” and a consensus target price of $191.67.

Globe Life Price Performance

Shares of GL opened at $171.07 on Monday. The company has a 50 day moving average of $178.36 and a two-hundred day moving average of $158.62. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.43. Globe Life Inc. has a twelve month low of $127.85 and a twelve month high of $191.55. The company has a market cap of $13.15 billion, a price-to-earnings ratio of 11.36 and a beta of 0.48.

Globe Life (NYSE:GL) last issued its quarterly earnings results on Wednesday, July 22nd. The company reported $3.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). Globe Life had a return on equity of 20.52% and a net margin of 19.58%.The business had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same period in the previous year, the company posted $3.05 earnings per share. The business’s revenue for the quarter was up 8.0% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. As a group, analysts predict that Globe Life Inc. will post 15.71 earnings per share for the current fiscal year.

Globe Life Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Monday, October 5th will be given a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Monday, October 5th. Globe Life’s dividend payout ratio is currently 8.76%.

Globe Life announced that its board has approved a stock buyback program on Monday, August 10th that authorizes the company to buyback $2.50 billion in shares. This buyback authorization authorizes the company to purchase up to 17.7% of its stock through open market purchases. Stock buyback programs are typically a sign that the company’s management believes its stock is undervalued.

Insider Activity at Globe Life

In other Globe Life news, CFO Thomas Peter Kalmbach sold 25,650 shares of the stock in a transaction dated Tuesday, July 28th. The stock was sold at an average price of $178.58, for a total value of $4,580,577.00. Following the completion of the sale, the chief financial officer directly owned 50,568 shares in the company, valued at approximately $9,030,433.44. This trade represents a 33.65% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO James Matthew Darden sold 50,000 shares of the firm’s stock in a transaction dated Friday, July 31st. The stock was sold at an average price of $182.43, for a total value of $9,121,500.00. Following the completion of the sale, the chief executive officer directly owned 58,451 shares of the company’s stock, valued at approximately $10,663,215.93. This represents a 46.10% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 151,908 shares of company stock worth $27,239,981 over the last ninety days. Corporate insiders own 2.11% of the company’s stock.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.